Comparison of the effect of fenugreek (Moota) with metformin tablets in improving clinical symptoms and metabolic status of patients with polycystic ovary syndrome (PCOS) - Trial IRCT20220130053874N1
Access comprehensive clinical trial information for IRCT20220130053874N1 through Pure Global AI's free database. This Phase 3 trial is sponsored by Iran University of Medical Sciences and is currently Completed. The study focuses on Polycystic ovarian syndrome.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
IRCT20220130053874N1
Phase 3
Completed
Trial Details
Iranian Registry Of Clinical Trial • IRCT20220130053874N1
Comparison of the effect of fenugreek (Moota) with metformin tablets in improving clinical symptoms and metabolic status of patients with polycystic ovary syndrome (PCOS)
Comparison of the effect of fenugreek tablets (Moota) with metformin tablets in improving the clinical symptoms and metabolic status of patients with polycystic ovary syndrome (PCOS) referred to the clinics of the University of Medical Sciences
Study Focus
Interventional
Sponsor & Location
Iran University of Medical Sciences
Iran
Timeline & Enrollment
Phase 3
Jan 04, 2021
N/A
ICD-10 Classifications
Polycystic ovarian syndrome
Ovarian dysfunction, unspecified
Ovarian dysfunction
Other ovarian dysfunction
Other and unspecified ovarian cysts
Data Source
Iranian Registry Of Clinical Trial
IRCT20220130053874N1
Non-Device Trial